Diabetes News and Research

Latest Diabetes News and Research

Senators make health reform positions known

The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.

6 Nov 2009

UCSF HIV researchers receive two NIH grants to improve health of HIV positive patients

UCSF HIV researchers have received two NIH grants of $1 million each to study the use of web-based, patient controlled personal health records to improve health and HIV prevention outcomes for HIV positive patients.

6 Nov 2009

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.

5 Nov 2009

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced financial results for the third quarter ended September 30, 2009.

5 Nov 2009

Neurometrix reports financial results for the third quarter of 2009

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its third quarter financial results.

5 Nov 2009

Cereplast confirms that all its resins are made without the use of BPA

Cereplast, Inc., a leading manufacturer of proprietary bio-based, sustainable plastics, confirmed today that all its resins are made without the use of Bisphenol A, commonly referred to as BPA. All products made with both Cereplast resin families, including the Compostables® and the Hybrids® are BPA free.

5 Nov 2009

Can American ginseng relieve health problems?

With the current outbreak of influenza-like illnesses, many people are trying to boost their immune systems with supplements. Ginseng is often a key ingredient, but its therapeutic use may extend far beyond that. Researchers are now investigating whether ginseng can help relieve health problems ranging from diabetes to depression to erectile dysfunction.

5 Nov 2009

Majority of U.S. physicians say patients have difficulty paying for medications and care

Fifty-eight percent of primary care doctors in the U.S. report their patients often have difficulty paying for medications and care, and half of U.S. doctors spend substantial time dealing with restrictions insurance companies place on their patients' care, according to findings from the 2009 Commonwealth Fund International Health Policy Survey published online today in the journal Health Affairs.

5 Nov 2009

Bursting common myths about psoriasis

Psoriasis is a real disability that affects approximately one million Canadians. A recent Canadian survey found that the causes and effects of this chronic, recurrent skin disorder are often misunderstood - and the result of these misperceptions can leave a lasting negative impact on those who suffer from this debilitating immune system disease.

5 Nov 2009

Employers sign up for first-of-its-kind health plan to control escalating health care costs

Employers are signing up for a first-of-its-kind health plan by UnitedHealthcare designed to help control the escalating costs of insuring diabetic and pre-diabetic employees and their families while improving their health.

5 Nov 2009

Surgery may not be the best option for children with obstructive sleep apnea

For children with obstructive sleep apnea, standard care often includes a tonsillectomy and adenoidectomy. But researchers at Saint Louis University say further research is needed to determine if surgery is the best option for these patients.

5 Nov 2009

New Merck set to begin global health care operations

Merck & Co., Inc. today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck is a global health care leader aimed at providing innovative, distinctive products and services that save and improve lives, while satisfying customer needs and creating long term shareholder value.

5 Nov 2009

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.

5 Nov 2009

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Alcatel-Lucent today announced that the Alcatel-Lucent TeleHealth Manager, a secure and reliable remote patient monitoring solution, has been cleared by the U.S. Food and Drug Administration (FDA) for marketing in the United States.

4 Nov 2009

Osiris Therapeutics reports financial results for the third quarter of 2009

Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its financial results for the third quarter of 2009.

4 Nov 2009

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

CPEX Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2009. For the quarter CPEX reported revenues of $5.0 million and a net loss of $872,000.

4 Nov 2009

Safeguard Scientifics reports financial results for the third quarter of 2009

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that third quarter consolidated net loss from continuing operations attributable to Safeguard common shareholders was $11.6 million, or $0.57 per share, compared with a net loss of $4.1 million, or $0.20 per share, in the same period of 2008.

4 Nov 2009

Entest BioMedical files second patent application in the treatment of COPD

Entest BioMedical announced today it has filed a second patent application in the area of Chronic Obstructive Pulmonary Disease (COPD). This new patent application builds upon the Company’s previously filed COPD patent application and involves the use of photoceutical devices to target stem cells toward areas impacted by COPD in the lungs.

4 Nov 2009

BD reports revenues of $1.898 billion for the fourth quarter of 2009

BD (Becton, Dickinson and Company) today reported quarterly revenues of $1.898 billion for the fourth fiscal quarter ended September 30, 2009, representing an increase of 5 percent from the prior-year period, or 8 percent excluding the unfavorable impact from foreign currency translation.

From BD (Becton, Dickinson and Company) 4 Nov 2009

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

Researchers from Mount Sinai School of Medicine report that cutting back on the consumption of processed and fried foods, which are high in toxins called Advanced Glycation End products (AGEs), can reduce inflammation and actually help restore the body's natural defenses regardless of age or health status. These benefits are present even without changing caloric or nutrient intake.

4 Nov 2009

Diabetes News and Research

Latest Diabetes News and Research

Senators make health reform positions known

UCSF HIV researchers receive two NIH grants to improve health of HIV positive patients

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

Neurometrix reports financial results for the third quarter of 2009

Cereplast confirms that all its resins are made without the use of BPA

Can American ginseng relieve health problems?

Majority of U.S. physicians say patients have difficulty paying for medications and care

Bursting common myths about psoriasis

Employers sign up for first-of-its-kind health plan to control escalating health care costs

Surgery may not be the best option for children with obstructive sleep apnea

New Merck set to begin global health care operations

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Osiris Therapeutics reports financial results for the third quarter of 2009

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

Safeguard Scientifics reports financial results for the third quarter of 2009

Entest BioMedical files second patent application in the treatment of COPD

BD reports revenues of $1.898 billion for the fourth quarter of 2009

Avoiding foods high in AGE toxins can reduce inflammation and restore the body's natural defenses

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Diabetes News and Research

Latest Diabetes News and Research

Innovation in neuroscience drug discovery - eBook eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in